Cell line · CVCL_3505
E.G7-OVA
Cancer cell line, Mus musculus. Mouse precursor T cell lymphoblastic lymphoma/leukemia. 16 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. E.G7-OVA. Cell lines, record CVCL_3505. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_3505
On this page
Cell line
As Cellosaurus gives it.
- Name
- E.G7-OVA
- Accession
- CVCL_3505
- RRID
- RRID:CVCL_3505
- Synonyms
- E.G7-Ova
- Species
- Mus musculus (Mouse)
- Sex
- Sex unspecified
- Age at sampling
- Age unspecified
- Category
- Cancer cell line
- Diseases
- Mouse precursor T cell lymphoblastic lymphoma/leukemia (NCIt C21925)
- Derived from
- Ascites (in situ)
- Cell type
- T-cell
- Parent
- EL4 (CVCL_0255)
- Entry created
- 2012-04-04
- Entry updated
- 2025-08-14
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers16
8 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Spatially Resolved Metabolomics of Optimal Cutting Temperature (OCT) Compound-Embedded Tumors. | Int J Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Intratumoral Virus-Like Particles Containing a TLR9 Agonist Combined with Systemic αPD-1 Activate Tumor-Specific CD8+ T Cells. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming. | Cancer Immunol Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Nanostructured lipid carriers based mRNA vaccine leads to a T cell-inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour model. | EBioMedicine | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Intradermal vaccination with a phytoglycogen nanoparticle and STING agonist induces cytotoxic T lymphocyte-mediated antitumor immunity. | NPJ Vaccines | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Specific targeting of cancer vaccines to antigen-presenting cells via an endogenous TLR2/6 ligand derived from cysteinyl-tRNA synthetase 1. | Mol Ther | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Evaluation of therapeutic PD-1 antibodies by an advanced single-molecule imaging system detecting human PD-1 microclusters. | Nat Commun | 2023 | Its Methods give the RRID and name the line | PubMed | |
| ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy. | Nat Commun | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Proteomic discovery of chemical probes that perturb protein complexes in human cells. | Mol Cell | 2023 | Its Methods give the RRID and name the line | PubMed | |
| The CIt protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells. | iScience | 2022 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 16
See all 16 papersRelatives1
| Relation | Cell line | Accession | Problem |
|---|---|---|---|
| Parent | EL4 | CVCL_0255 |
Source Cell lines
Cell banks2
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_3505
GET https://conductscience.org/api/cell-lines/v1/CVCL_3505/problems